Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusinessMarkets

Stimulus package 2.0 to benefit Rs 30,000 cr PVC pipes segment; Finolex, Astral Poly top buys

The domestic brokerage house initiates a buy rating on Finolex Industries with a 2-year target price of Rs 492 while Astral Poly is also a buy with a 2-year target price of Rs 1081.

May 21, 2020 / 08:25 AM IST
Maharashtra Seamless

Maharashtra Seamless

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

The Indian plastic pipe industry is likely to clock 10 percent CAGR over FY20-25E to reach Rs 50,000 billion by FY25E from Rs30,000 crore currently, driven by government’s initiatives like “Housing for All” by 2022, “Nal se Jal” by 2024, project AMRUT & Swachh Bharat Mission, Reliance Securities said in a note.

The stimulus package for Agri and Housing sector announced by the Finance Minister recently is likely to benefit the PVC Pipes segment. The government has announced stimulus packages in V tranches to fight against disruption of COVID19.

“We believe package III is likely to benefit Farmers and Housing sector,” said the note. Reliance Securities initiates coverage with a buy rating on Finolex Industries, and Astral Poly with a 2-year investment horizon.

The domestic brokerage house initiates a buy rating on Finolex Industries with a 2-year target price of Rs 492 while Astral Poly is also a buy with a 2-year target price of Rs 1081.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The note further added that the impact of COVID-led disruption was limited in 4QFY20 and significant in 1QFY21. As 1Q has historically been a lean quarter with low volume, Reliance Securities expects meaningful demand recovery in 2QFY21E.
Anti-Dumping Duty (ADD) on CPVC resin/compound:

The Government has imposed anti-dumping duty (ADD) on imports of CPVC resin/ compound from China and Korea for five years (February 2020-2025). Earlier, the ADD was imposed on a provisional basis for six months since August 2019.

The share of imports from China and South Korea declined by 6 percent during the Sept-Dec’19 period, which benefitted the larger players with strong margin expansion owing to low-cost inventory, especially in 3QFY20.

“We believe this high margin is unlikely to sustain, going forward due to price hike of CPVC resin in the near-term,” said the note.

Initiate Coverage with BUY Recommendation:

Finolex Industries (Finolex): 



 The company is the largest player in agriculture pipes and 2nd largest player in the Indian pipes sector with a market share of 9 percent.

Finolex has increased its PVC pipes capacity to 370,000 TPA currently from 250,000 TPA in FY15, while resin capacity remains at 272,000 TPA.

It has forayed into the CPVC segment with a tie-up with Lubrizol in February 2017. Reliance Securities initiated coverage on Finolex with a buy recommendation and 2-Year Target Price of Rs492 (valuing it at 16x FY23E earnings).



Astral Poly Technik (Astral):
The company is the leader in CPVC pipes and fittings market in India. Astral had innovated CPVC pipes in India 2 decades ago and gained significant traction by introducing the various applications.With the expansion in Odisha, its total capacity will increase to 250,000 MTPA by FY21E. Astral has entered the adhesives business through the acquisition of Seal IT and Resinova, which has helped to gain a strong base.Reliance Securities initiated coverage on Astral with a BUY recommendation and 2-Year Target Price of Rs1,081 (45x FY23E earnings).

Disclaimer: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Moneycontrol News

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347